Search

Search Constraints

You searched for: Author/Creator Zaroui, Amira

Search Results

1. Describing mode of death in three major cardiac amyloidosis subtypes to improve management and survival. (3rd April 2022)

2. Evaluation of a new ELISA assay for monoclonal free‐light chain detection in patients with cardiac amyloidosis. Issue 3 (24th June 2022)

3. History of extracardiac/cardiac events in cardiac amyloidosis: prevalence and time from initial onset to diagnosis. (29th October 2021)

4. Natural course and determinants of short-term kidney function decline in hereditary transthyretin amyloidosis: a French observational study. (2nd January 2023)

5. Natural history and impact of treatment with tafamidis on major cardiovascular outcome‐free survival time in a cohort of patients with transthyretin amyloidosis. (9th November 2020)

6. Prevalence and determinants of iron deficiency in cardiac amyloidosis. (6th February 2022)

7. Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan® in transthyretin wild‐type cardiac amyloidosis. (22nd December 2020)